ADDINEX TECHNOLOGIES, INC.
Platform for Preventing Prescription Drug
Addiction & Misuse
Doctors write over 150 million opioid prescriptions annually to 50 million Americans. 10 million people misuse opioids and over 2 million people are addicted leading to over 60,000 deaths each year, more than from car accidents. Most attempts to combat the problem have focused on treating those already addicted. We at Addinex are focused on both stopping addiction before it starts and treating those with Opioid Use Disorder.
We believe that the onset of opioid addiction is driven by three key factors. The ADX system is designed to counter each of these problems with the goal of stopping the epidemic in its tracks.
Up to 92% of patients have unused pills after surgery according to a study by Johns Hopkins University. The American Journal of Law and Medicine states that there is a "paucity of trustworthy, current data" in prescribing opioids.
Lack of Disposal
The JHU study found that more than 90% of patients fail to properly dispose of leftover pills leading to over 3 billion opioids annually retained or diverted. 50% of illicitly used pills come from one's own or a friend's medicine cabinet.
Risk of addiction increases with initial time of use. A University of Michigan study found that one in 16 users of opioids become chronic users after just one dose and the risk of prolonged use increases dramatically after 4-5 days. You have a one in five chance of still being on the drug after one year if you take an opioid for just 10 days.
Addinex has developed a low-cost, patented opioid dispensing system to prevent addiction and overdose via password-protected dosage access, real-time patient education, excess pill destruction, and data feedback on actual usage patterns. Like the proven efficacy of seatbelts in cars and helmets for motorcyclists, our device adds a level of protection for users of a useful, but potentially dangerous product.
Easy to Use App
Each dose requires a unique passcode that matches only the patient with the device. Passcodes are only released to the actual user and on the prescription's schedule.
The ADX device does not allow a patient to access the next pill until the minimum time interval has passed based on the prescription. For example, one pill 2-4 times per day allows one pill every six hours
All passcodes must be requested through our digital database via our mobile app, web app, text, or call-in service (coming soon). The request process is quick and easy.
The ADX device has no electronics making it very cost effective. All of the patient specific features of the system are accessed via the related App or other methods.
Our patented device and integrated system offer the following unique benefits to patients, doctors, insurance companies, pharmacies, and society.
Addiction Cost Savings
According to the U.S. Council of Economic Advisers, medical insurers spend over $65 billion annually on opioid addiction. Greater control over initial opioid usage and elimination of access to excess drugs will result in significant savings to the bottom line.
Doctors write over 150 million opioid prescriptions with 3.3 billion excess pills being retained annually. Since our data can help doctors avoid over-prescribing, insurance companies can save billions of dollars from lower prescribing levels and less diversion of pills for illicit use.
How It Works
Step 5 - Get Educated
Addinex will provide you with valuable information (e.g., possible side-effects, addiction statistics, etc.) each time you take a dose. We'll monitor your pain levels and suggest consideration of over-the-counter medications as the pain subsides. We'll also warn you when you've been taking more pills than is typical for similar patients.
Step 6 - Return Device
Once your pain subsides, it's time to return the device. To avoid the risk of access to pills by unauthorized users and to keep yourself safe from using the pills in the future without a doctor's oversight, we require that the ADX device be returned in our easy-to-use pre-paid mailer which can be deposited into any mailbox. Addinex will alert doctors if patients fail to return the device which could compromise access to future prescriptions.
Partners / COMPETITIONs
US Patent #10335349